Doctor profile · Federal record
Dr. Sharif Currimbhoy, M.D.
Dermatology Physician (CMS: Dermatology) · Garland, TX
- NPI 1417367095
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 12 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1614 Surrey CT
Garland, TX 750431353
(469) 223-4258 - Mailing address
-
209 N Bonnie Brae St Ste 205
Denton, TX 762013748
Credentials & registration
- NPI registered
- May 2014 — 12 yrs on file
- Profile last updated
- March 29, 2018
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #R4683
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417367095. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
16,305
Distinct HCPCS
10
Medicare allowed
$755,951
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 8,814 | 1,070 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,790 | 1,183 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,724 | 1,183 | $49 | |
17110 |
Destruction of skin growth, 1-14 growths | 880 | 683 | $104 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 789 | 546 | $122 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 689 | 420 | $161 | |
11102 |
Biopsy of related skin growth, first growth | 685 | 554 | $81 | |
11103 |
Biopsy of related skin growth, each additional growth | 205 | 155 | $48 | |
11106 |
Incision biopsy, first skin growth | 162 | 145 | $149 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 152 | 152 | $107 |
In context: peer comparison
Among 2 peers in Garland Dermatology Physician, average services per provider: 523. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$621
Transactions
29
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 9 | $192.93 | |
| Amgen INC. | 4 | $83.24 | |
| Incyte Corporation | 3 | $67.43 | |
| Ucb, INC. | 2 | $60.69 | |
| Mayne Pharma Commercial LLC | 3 | $49.77 | |
| Arcutis Biotherapeutics, INC. | 2 | $42.16 | |
| Dermavant Sciences, INC. | 2 | $33.42 | |
| Genzyme Corporation | 1 | $29.85 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $24.00 | |
| Galderma Laboratories, L.P. | 1 | $23.79 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $13.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,012
Patients
1,725
Total drug cost
$184,786
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 866 | 409 | $14,814 |
| Triamcinolone Acetonide | Generic | 785 | 523 | $6,356 |
| Betamethasone Dipropionate | Generic | 317 | 195 | $13,546 |
| Metronidazole | Generic | 254 | 168 | $17,374 |
| Mupirocin | Generic | 188 | 147 | $1,846 |
| Gabapentin | Generic | 151 | 49 | $1,600 |
| Doxycycline Hyclate | Generic | 145 | 70 | $3,852 |
| Clobetasol Propionate | Generic | 95 | 57 | $5,927 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 53 | 32 | $396 |
| Clindamycin Phosphate | Generic | 36 | 25 | $1,268 |
Frequently asked questions
What is Dr. Sharif Currimbhoy's medical specialty?
Dr. Sharif Currimbhoy practices Dermatology Physician in Garland, TX.
Where does Dr. Sharif Currimbhoy practice?
Dr. Sharif Currimbhoy practices at 1614 Surrey CT, Garland, TX 750431353. Office phone: 4692234258.
What is Dr. Sharif Currimbhoy's NPI?
Dr. Sharif Currimbhoy's National Provider Identifier (NPI) is 1417367095, issued by NPPES.
Does Dr. Sharif Currimbhoy accept Medicare assignment?
Yes. Dr. Sharif Currimbhoy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sharif Currimbhoy commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.